Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 1.06x is 33% above its 5-year average of 0.79x, near the high end of its 5-year range (-8.94x–2.30x).
53.54% above its 12-month average of 0.69x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 0.04x.
INTEREST COVERAGE RATIO
1.06x
INTEREST COVERAGE RATIO AVG TTM
0.69x
INTEREST COVERAGE RATIO AVG 3Y
0.48x
INTEREST COVERAGE RATIO AVG 5Y
0.79x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+53.54%
CURRENT VS 3Y AVG
+121.17%
CURRENT VS 5Y AVG
+33.35%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 323 covered companies
CURRENT VS SECTOR MEDIAN
+125.24%
vs the sector median at left
Certara, Inc.
Market Cap
$1.57B
Interest Coverage Ratio
1.06x
TTM Avg
0.69x
3Y Avg
0.48x
5Y Avg
0.79x
Market Cap
$1.52B
Interest Coverage Ratio
0.02x
TTM Avg
0.02x
3Y Avg
0.02x
5Y Avg
0.02x
Market Cap
$1.52B
Interest Coverage Ratio
9.81x
TTM Avg
8.66x
3Y Avg
9.09x
5Y Avg
12.26x
Market Cap
$1.52B
Interest Coverage Ratio
-131.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.51B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.65B
Interest Coverage Ratio
-3.88x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
Market Cap
$1.65B
Interest Coverage Ratio
4.05x
TTM Avg
2.04x
3Y Avg
1.94x
5Y Avg
1.94x
Market Cap
$1.66B
Interest Coverage Ratio
-17.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.46B
Interest Coverage Ratio
0.60x
TTM Avg
0.60x
3Y Avg
0.60x
5Y Avg
0.60x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | $1.57B | 1.06x | 0.69x | 0.48x | 0.79x |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 0.02x | 0.02x | 0.02x | 0.02x |
| Innoviva, Inc. (INVA)vs › | $1.52B | 9.81x | 8.66x | 9.09x | 12.26x |
| GH Research PLC (GHRS)vs › | $1.52B | -131.05x | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -3.88x | 0.61x | 0.61x | 0.61x |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 4.05x | 2.04x | 1.94x | 1.94x |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.66B | -17.85x | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 0.60x | 0.60x | 0.60x | 0.60x |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 30.72x | 19.49x | 15.15x | 21.38x |
Interest Coverage
1.1x
Debt/Equity
0.30
Current Ratio
2.55
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 0.04x |
| 2026-03-31 | 0.80x |
| 2025-12-31 | 0.02x |
| 2025-09-30 | 0.60x |
| 2025-06-30 | 1.99x |
| 2025-03-31 | 1.59x |
| 2024-12-31 | 1.20x |
| 2024-09-30 | 0.50x |
| 2024-06-30 | -1.62x |
| 2024-03-31 | -0.22x |
| 2023-12-31 | -1.44x |
| 2023-09-30 | -8.94x |
| 2023-06-30 | 2.30x |
| 2023-03-31 | 1.36x |
| 2022-12-31 | 2.09x |
| 2022-09-30 | 2.08x |
| 2022-06-30 | 1.07x |
| 2022-03-31 | 1.90x |
| 2021-12-31 | 1.05x |
| 2021-09-30 | -0.23x |
| 2021-06-30 | 0.83x |
| 2021-03-31 | 1.43x |
| 2020-12-31 | -9.76x |
| 2020-09-30 | 1.26x |
| 2020-06-30 | 1.94x |
| 2020-03-31 | 1.17x |
| 2019-12-31 | 0.58x |
